Skip to content
Biocidium Biopharmaceuticals Inc. Logo
  • Home
  • Company
  • Products
    • Pipeline
    • Antibiotics
    • Antifungals
    • Oncology
  • Partnering
  • News
  • Contact

Genomic sequencing reveals MRSA spread within, between ICUs

Whole-genome sequencing revealed the spread of MRSA strains among patients, health care workers and the environment, including within — and even between — ICUs, according [...]

The dangerous legacy of COVID-19: A rise in antimicrobial resistance

In their desperation, doctors and patients have been using an array of antimicrobial products in a manner that will lead to more harm than good. [...]

3 cases of pan-resistant C. auris identified in New York

Three patients with Candida auris resistant to all three classes of antifungals commonly prescribed for the illness have been identified through active and ongoing surveillance [...]

Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019

Three chronically ill patients in New York were identified as having pan-resistant C. auris after receipt of antifungal medications. No transmission of the pan-resistant isolates [...]

Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

A series of breakthroughs in our understanding of the links between infections and cancer in the past 60 years has been accompanied by increasing prospects [...]

Infections caused 13% of cancers in 2018

2.2 million new cases worldwide Date: January 6, 2020 Source: Healio.com Infectious Disease News Author: de Martel C, et al. Lancet Glob Health. 2019 Excerpt: [...]

The evolution of antibiotic resistance

Understanding how ABR evolves and spreads is key to improving antibiotic treatment strategies. Date: Sep 13, 2109 Source: Science Author: R. Craig MacLean, Alvaro San [...]

Skin shedding may contribute to spread of C. auris

Pathogenic yeast's mechanisms of transmission may be via skin. Date: June 23, 2019 Source: Healio Infectious Disease News Excerpt: "Patients colonized with Candida auris carry [...]

Our antibiotics are no match for superbugs, and it’s a ‘global crisis,’ UN report says

Drug-resistant diseases cause at least 700,000 deaths globally a year, including 230,000 deaths from multidrug-resistant tuberculosis, according to the report, which was published Monday. In the [...]

AMR Fungus Spanning the Globe in a Climate of Secrecy

The rise of Candida Auris embodies a serious and growing public health threat: drug-resistant germs. Date: April 6, 2019 Source: The New York Times Author: [...]

12Next

Categories

  • Antibiotic resistance (83)
    • CRE (12)
    • MRSA (15)
    • VRE (3)
  • Antifungal (8)
  • Antimicrobial general reference (13)
  • Biocidium company news (1)
  • Biocidium product updates (1)
  • Oncology (10)
  • Science and Industry developments (34)

Contact Info

Email: info@biocidium.com

Web: Contact Us

BIOCIDIUM

Biocidium is a clinical-stage bio-pharmaceutical company focused on the discovery & development of novel antibiotics, antifungals and cancer treatments. Our primary products are developed for the treatment of multi-drug resistant (MDR) bacterial infections as well as breakthrough treatments for cancer and fungal infections
Terms of Use | Privacy Policy

NEWS

  • Genomic sequencing reveals MRSA spread within, between ICUs
  • The dangerous legacy of COVID-19: A rise in antimicrobial resistance
  • 3 cases of pan-resistant C. auris identified in New York
  • Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019

CONTACT

Email: info@biocidium.com

Web: Contact us

©2023 Biocidium Biopharmaceuticals | All Rights Reserved | info@biocidium.com | media
Page load link